Meridian Bioscience Inc also files under VIV0; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 31, 2023 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Grant(A) | 8K | — | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 22K | — | — |
| Jan 31, 2023 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Disposed to issuer(D) | 4K | $27.03as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 9K | $16.66as filed | — |
| Jan 31, 2023 | Kitzmiller Andrew S. | Executive Vice President & CFO | Disposed to issuer(D) | 19K | — | — |
| Jan 31, 2023 | Rice John McCune Jr. | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 31, 2023 | Smith Julie Diana | Sr VP, Controller, PAO | Disposed to issuer(D) | 33K | — | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 9K | $15.36as filed | — |
| Jan 31, 2023 | Williams Felicia | Director | Disposed to issuer(D) | 6K | $13.25as filed | — |
| Jan 31, 2023 | Williams Felicia | Director | Disposed to issuer(D) | 6K | $12.64as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 16K | — | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 9K | $17.03as filed | — |
| Jan 31, 2023 | Weltzien Lourdes | Executive VP, Life Science | Disposed to issuer(D) | 12K | $15.52as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 6K | $13.25as filed | — |
| Jan 31, 2023 | Rice John McCune Jr. | Director | Disposed to issuer(D) | 6K | $12.64as filed | — |
| Jan 31, 2023 | Williams Felicia | Director | Disposed to issuer(D) | 12K | $18.85as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 12K | $21.20as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 17K | $23.54as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 6K | $12.64as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 6K | $13.25as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 9K | $17.03as filed | — |
| Jan 31, 2023 | Williams Felicia | Director | Disposed to issuer(D) | 17K | $23.54as filed | — |
| Jan 31, 2023 | Williams Felicia | Director | Disposed to issuer(D) | 10K | — | — |
| Jan 31, 2023 | Smith Julie Diana | Sr VP, Controller, PAO | Disposed to issuer(D) | 2K | $27.03as filed | — |
| Jan 31, 2023 | Weltzien Lourdes | Executive VP, Life Science | Disposed to issuer(D) | 12K | $15.12as filed | — |
| Jan 31, 2023 | Kenny John P. | Chief Executive Officer, Director, 10% Owner | Disposed to issuer(D) | 83K | $15.12as filed | — |
| Jan 31, 2023 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Disposed to issuer(D) | 10K | $19.40as filed | — |
| Jan 31, 2023 | Williams Felicia | Director | Disposed to issuer(D) | 9K | $17.03as filed | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 6K | $12.64as filed | — |
| Jan 31, 2023 | Weltzien Lourdes | Executive VP, Life Science | Disposed to issuer(D) | 10K | $14.34as filed | — |
| Jan 31, 2023 | Rice John McCune Jr. | Director | Disposed to issuer(D) | 6K | $13.25as filed | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 9K | $15.36as filed | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 12K | $17.80as filed | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 6K | $16.66as filed | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 9K | $15.82as filed | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 10K | $21.20as filed | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 6K | $13.25as filed | — |
| Jan 31, 2023 | Rice John McCune Jr. | Director | Disposed to issuer(D) | 12K | $17.80as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 6K | $12.64as filed | — |
| Jan 31, 2023 | Bihl Anthony P III | Director | Disposed to issuer(D) | 6K | $12.64as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 17K | $23.54as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 9K | $15.82as filed | — |
| Jan 31, 2023 | Kenny John P. | Chief Executive Officer, Director, 10% Owner | Disposed to issuer(D) | 84K | $15.52as filed | — |
| Jan 31, 2023 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Disposed to issuer(D) | 12K | $15.12as filed | — |
| Jan 31, 2023 | Weltzien Lourdes | Executive VP, Life Science | Disposed to issuer(D) | 3K | $19.70as filed | — |
| Jan 31, 2023 | Sazdanoff Catherine | Director | Disposed to issuer(D) | 12K | $17.80as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 12K | $17.80as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 12K | $21.20as filed | — |
| Jan 31, 2023 | Kenny John P. | Chief Executive Officer, Director, 10% Owner | Disposed to issuer(D) | 66K | $23.90as filed | — |
| Jan 31, 2023 | Rice John McCune Jr. | Director | Disposed to issuer(D) | 9K | $17.03as filed | — |
| Jan 31, 2023 | Kenny John P. | Chief Executive Officer, Director, 10% Owner | Disposed to issuer(D) | 268K | — | — |
| Jan 31, 2023 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Disposed to issuer(D) | 12K | $15.52as filed | — |
| Jan 31, 2023 | Kitzmiller Andrew S. | Executive Vice President & CFO | Disposed to issuer(D) | 5K | $9.26 | $46K |
| Jan 31, 2023 | Kenny John P. | Chief Executive Officer, Director, 10% Owner | Grant(A) | 47K | — | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 28K | — | — |
| Jan 31, 2023 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Disposed to issuer(D) | 43K | — | — |
| Jan 31, 2023 | Weltzien Lourdes | Executive VP, Life Science | Disposed to issuer(D) | 86K | — | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 9K | $17.03as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 5K | — | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 11K | $21.20as filed | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 9K | $15.36as filed | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 6K | $13.25as filed | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 9K | $8.17 | $69K |
| Jan 31, 2023 | Smith Julie Diana | Sr VP, Controller, PAO | Disposed to issuer(D) | 26K | — | — |
| Jan 31, 2023 | Weltzien Lourdes | Executive VP, Life Science | Grant(A) | 8K | — | — |
| Jan 31, 2023 | Bihl Anthony P III | Director | Disposed to issuer(D) | 6K | $13.25as filed | — |
| Jan 31, 2023 | Bihl Anthony P III | Director | Disposed to issuer(D) | 15K | — | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 9K | $13.20as filed | — |
| Jan 31, 2023 | Smith Julie Diana | Sr VP, Controller, PAO | Grant(A) | 3K | — | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 17K | $23.54as filed | — |
| Jan 31, 2023 | Bihl Anthony P III | Director | Disposed to issuer(D) | 5K | $10.50 | $48K |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 9K | $17.03as filed | — |
| Jan 31, 2023 | Kitzmiller Andrew S. | Executive Vice President & CFO | Grant(A) | 8K | — | — |
| Jan 31, 2023 | Anderson James M. | Director | Disposed to issuer(D) | 9K | $15.36as filed | — |
| Jan 31, 2023 | Ellingwood Dwight E | Director | Disposed to issuer(D) | 17K | — | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 17K | $23.54as filed | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 6K | $12.64as filed | — |
| Jan 31, 2023 | McIlwraith John | Director | Disposed to issuer(D) | 12K | $17.80as filed | — |
| Jan 6, 2023 | Anderson James M. | Director | Option exercise(M) | 9K | — | $0 |
| Jan 6, 2023 | Anderson James M. | Director | Option exercise(M) | 9K | $20.38as filed | — |
| Dec 6, 2022 | Smith Julie Diana | Sr VP, Controller, PAO | Tax withholding(F) | 374 | $31.71as filed | — |
| Nov 15, 2022 | Weltzien Lourdes | EVP, Life Science | Tax withholding(F) | 4K | $31.83as filed | — |
| Nov 15, 2022 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Tax withholding(F) | 4K | $31.83as filed | — |
| Nov 15, 2022 | Smith Julie Diana | Sr VP, Controller, PAO | Tax withholding(F) | 2K | $31.83as filed | — |
| Nov 4, 2022 | Smith Julie Diana | Sr VP, Controller, PAO | Tax withholding(F) | 397 | $32.01as filed | — |
| Nov 4, 2022 | Kenny John P. | Chief Executive Officer, Director | Tax withholding(F) | 4K | $32.01as filed | — |
| Nov 4, 2022 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Tax withholding(F) | 788 | $32.01as filed | — |
| Nov 4, 2022 | Weltzien Lourdes | EVP, Life Science | Tax withholding(F) | 566 | $32.01as filed | — |
| Oct 3, 2022 | Kenny John P. | Chief Executive Officer, Director | Tax withholding(F) | 40K | $31.53as filed | — |
| Sep 16, 2022 | Smith Julie Diana | Sr VP, Controller, PAO | Tax withholding(F) | 360 | $32.14as filed | — |
| Sep 16, 2022 | Serafini-Lamanna Tony | Executive VP-Diagnostics | Tax withholding(F) | 357 | $32.14as filed | — |
| Jun 27, 2022 | Kenny John P. | Chief Executive Officer, Director | Option exercise(M) | 61K | $10.10 | $621K |
| Jun 27, 2022 | Kenny John P. | Chief Executive Officer, Director | Sell(S) | 61K | $30.39as filed | — |
| Jun 27, 2022 | Kenny John P. | Chief Executive Officer, Director | Option exercise(M) | 61K | — | $0 |
| Jun 24, 2022 | Kenny John P. | Chief Executive Officer, Director | Option exercise(M) | 14K | $10.10 | $137K |
| Jun 24, 2022 | Kenny John P. | Chief Executive Officer, Director | Sell(S) | 14K | $30.00as filed | — |
| Jun 24, 2022 | Kenny John P. | Chief Executive Officer, Director | Option exercise(M) | 14K | — | $0 |
| Jun 23, 2022 | Kenny John P. | Chief Executive Officer, Director | Option exercise(M) | 15K | — | $0 |
| Jun 23, 2022 | Kenny John P. | Chief Executive Officer, Director | Option exercise(M) | 15K | $10.10 | $148K |
| Jun 23, 2022 | Kenny John P. | Chief Executive Officer, Director | Option exercise(M) | 5K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Meridian Bioscience Inc, SEC CIK 0000794172. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under VIVO and shows every filing by that issuer (also filed as VIV0).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for VIVO